StemExpress today released the following concerning CMP’s 8th video
While the Los Angeles Superior Court ruled on August 21st that it is likely that The Center for Medical Progress and David Daleiden violated California’s criminal law prohibiting the illegal recording of private conversations, the court’s ruling permits these criminal defendants to continue their release of heavily edited, highly-deceptive videos targeting StemExpress.
In a “preview” video released immediately following the court’s ruling, the criminal defendants claim StemExpress “admitted” to receiving “intact fetuses” from Planned Parenthood. However, a cursory review of the unedited video or transcriptreveals that the entire conversation was unequivocally discussing “intact” fetal livers, which are used by StemExpress for the development of isolated cells that are urgently needed by scientists and medical researchers working to cure cancer, diabetes and Alzheimer’s disease. In fact, CMP itself has previously acknowledged that this portion of the conversation refers solely to fetal livers, but nonetheless continues to lodge unsupported false accusations at StemExpress.
StemExpress’s CEO, Cate Dyer, added the following personal response to these latest allegations:
Consistent with the company’s prior public statements, StemExpress has never requested, received or provided to a researcher an ‘intact fetus.’ CMP’s and Daleiden’s continued lies reflect a sad attempt to malign StemExpress and me personally. As anyone can see and read, the entire discussion was, in fact, about ‘intact livers,’ which are used by StemExpress to develop and purify isolated cells used by our customers to support their critical scientific research. My use of the term ‘intact cases’ is a medical term of art that refers solely to ‘intact livers,’ as there was absolutely no mention of ‘intact fetuses’ at any point in over two hours of illegally recorded video.”
StemExpress will continue to pursue its claims for damages and to hold CMP and Daleiden accountable for their illegal conduct.